OR Royalties Inc. $OR Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. reduced its stake in shares of OR Royalties Inc. (NYSE:OR) by 45.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 112,139 shares of the basic materials company’s stock after selling 93,037 shares during the period. JPMorgan Chase & Co.’s holdings in OR Royalties were worth $4,495,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of OR. Van ECK Associates Corp grew its holdings in OR Royalties by 20.5% in the third quarter. Van ECK Associates Corp now owns 15,561,057 shares of the basic materials company’s stock valued at $623,686,000 after purchasing an additional 2,650,333 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in OR Royalties by 39.2% during the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 7,543,667 shares of the basic materials company’s stock worth $302,419,000 after purchasing an additional 2,124,421 shares during the period. Massachusetts Financial Services Co. MA acquired a new position in shares of OR Royalties in the 3rd quarter valued at $41,210,000. Goldman Sachs Group Inc. boosted its holdings in shares of OR Royalties by 152.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,256,583 shares of the basic materials company’s stock valued at $26,539,000 after purchasing an additional 758,815 shares during the last quarter. Finally, Invesco Ltd. grew its stake in shares of OR Royalties by 85.3% during the 3rd quarter. Invesco Ltd. now owns 1,543,366 shares of the basic materials company’s stock valued at $61,858,000 after buying an additional 710,654 shares during the period. 68.52% of the stock is owned by institutional investors and hedge funds.

OR Royalties Trading Up 0.4%

Shares of OR stock opened at $40.27 on Friday. The company’s fifty day simple moving average is $41.39 and its 200-day simple moving average is $37.95. OR Royalties Inc. has a 52 week low of $18.99 and a 52 week high of $48.06. The company has a market cap of $7.56 billion, a PE ratio of 36.95 and a beta of 0.83.

OR Royalties (NYSE:OR) last announced its quarterly earnings results on Wednesday, February 18th. The basic materials company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.01. OR Royalties had a net margin of 74.30% and a return on equity of 12.73%. The firm had revenue of $90.47 million during the quarter, compared to analysts’ expectations of $90.80 million. Equities research analysts expect that OR Royalties Inc. will post 0.62 EPS for the current fiscal year.

OR Royalties Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.055 per share. This represents a $0.22 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Tuesday, March 31st. OR Royalties’s payout ratio is currently 20.18%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. TD Securities restated a “hold” rating on shares of OR Royalties in a report on Monday, February 23rd. Weiss Ratings reissued a “buy (b)” rating on shares of OR Royalties in a research report on Monday, December 29th. Jefferies Financial Group restated a “hold” rating and set a $38.00 price target on shares of OR Royalties in a research note on Sunday, December 7th. Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of OR Royalties in a report on Wednesday, February 4th. Finally, Wall Street Zen raised OR Royalties from a “buy” rating to a “strong-buy” rating in a research note on Saturday, March 21st. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $38.25.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.